` 301047 (Sino Biological Inc) vs Shanghai Composite Comparison - Alpha Spread

301047
vs
S
Shanghai Composite

Over the past 12 months, Sino Biological Inc has underperformed Shanghai Composite, delivering a return of +18% compared to the Shanghai Composite's +25% growth.

Stocks Performance
301047 vs Shanghai Composite

Loading
301047
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
301047 vs Shanghai Composite

Performance Gap Between 301047 and SSEC
HIDDEN
Show

Performance By Year
301047 vs Shanghai Composite

Loading
301047
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sino Biological Inc vs Peers

Shanghai Composite
301047
RYI
GLDD
AVGR
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sino Biological Inc
Glance View

Market Cap
9B CNY
Industry
Biotechnology

Sino Biological Inc. emerged as a pivotal player in the life sciences sphere from its inception, carving a niche through its extensive portfolio of biological reagents, particularly recombinant proteins and antibodies. This Beijing-headquartered company swiftly gained acclaim by developing high-quality, cost-effective products that cater to the needs of researchers, pharmaceutical companies, and biotechnology firms worldwide. Its expansive catalog, boasting thousands of products, is meticulously curated to support research and development in areas such as immunology, cancer research, and infectious diseases. Sino Biological’s facility, equipped with state-of-the-art technology, combines automation with expert human oversight to ensure precision in production, fundamentally driving its reputation for reliability and innovation. At the heart of Sino Biological’s business model lies a commitment to accelerating the pace of biomedical research through its comprehensive suite of products and services. The company generates revenue by not only selling its own products but also by offering custom services, including protein production, antibody development, and assay development, tailored to meet specific client needs. By employing a business strategy that emphasizes collaboration and tailored solutions, Sino Biological successfully fosters long-term partnerships with its clients. This approach not only fortifies its foothold in the industry but also ensures a steady income stream as it plays a vital role in facilitating breakthroughs in medical research and development globally.

Sino Biological Inc Intrinsic Value
HIDDEN
Show
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett